Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial

OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagiwara, Akiyoshi, Tanaka, Noriko, Uemura, Tatsuki, Matsuda, Wataru, Kimura, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223629/
https://www.ncbi.nlm.nih.gov/pubmed/28039291
http://dx.doi.org/10.1136/bmjopen-2016-012850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223629/
https://www.ncbi.nlm.nih.gov/pubmed/28039291
http://dx.doi.org/10.1136/bmjopen-2016-012850

Ejemplares similares